Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-26 @ 1:05 AM
Study NCT ID:
NCT00392834
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2006-10-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
Sponsor:
AIDS Malignancy Consortium
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
AMC-048
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None